9TH0 Stock Overview
Epsilon Healthcare Limited operates as a healthcare and pharmaceuticals company primarily in Australia and Canada.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Epsilon Healthcare Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.0075 |
| 52 Week High | AU$0.028 |
| 52 Week Low | AU$0.0035 |
| Beta | 0.92 |
| 1 Month Change | 0% |
| 3 Month Change | -11.76% |
| 1 Year Change | -6.25% |
| 3 Year Change | -94.55% |
| 5 Year Change | -97.75% |
| Change since IPO | -96.85% |
Recent News & Updates
Recent updates
Shareholder Returns
| 9TH0 | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | 0% | 0.9% | -1.0% |
| 1Y | -6.3% | -27.7% | 2.0% |
Return vs Industry: 9TH0 exceeded the German Pharmaceuticals industry which returned -26.3% over the past year.
Return vs Market: 9TH0 underperformed the German Market which returned 4.6% over the past year.
Price Volatility
| 9TH0 volatility | |
|---|---|
| 9TH0 Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 7.1% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 9TH0's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine 9TH0's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2016 | n/a | Daniel Sanghera | epsilonhealthcare.com.au |
Epsilon Healthcare Limited operates as a healthcare and pharmaceuticals company primarily in Australia and Canada. It engages in the manufacture and distribution of hydroponics equipment, materials, and nutrients; and development and delivery of medicinal cannabis, as well as provides turnkey cannabis cultivation solutions. The company was formerly known as THC Global Group Limited and changed its name to Epsilon Healthcare Limited in February 2021.
Epsilon Healthcare Limited Fundamentals Summary
| 9TH0 fundamental statistics | |
|---|---|
| Market cap | €4.36m |
| Earnings (TTM) | -€3.58m |
| Revenue (TTM) | €4.36m |
1.0x
P/S Ratio-1.2x
P/E RatioIs 9TH0 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 9TH0 income statement (TTM) | |
|---|---|
| Revenue | AU$7.21m |
| Cost of Revenue | AU$5.09m |
| Gross Profit | AU$2.12m |
| Other Expenses | AU$8.05m |
| Earnings | -AU$5.93m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.02 |
| Gross Margin | 29.46% |
| Net Profit Margin | -82.17% |
| Debt/Equity Ratio | 27.1% |
How did 9TH0 perform over the long term?
See historical performance and comparison